{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:15:08Z","timestamp":1786324508458,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.amjopharm.2011.12.001","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T01:10:21Z","timestamp":1326157821000},"page":"25-36.e2","source":"Crossref","is-referenced-by-count":17,"title":["Warfarin Use in Nursing Home Residents: Results from the 2004 National Nursing Home Survey"],"prefix":"10.1016","volume":"10","author":[{"given":"Parinaz K.","family":"Ghaswalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer E.","family":"Harpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia W.","family":"Slattum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2011.12.001_bib1","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/NRL.0b013e31815cffae","article-title":"Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the united states","volume":"14","author":"Lakshminarayan","year":"2008","journal-title":"Neurologist"},{"issue":"6 suppl","key":"10.1016\/j.amjopharm.2011.12.001_bib3","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","article-title":"Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Singer","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib4","doi-asserted-by":"crossref","first-page":"e873","DOI":"10.1161\/01.STR.0000223048.70103.F1","volume":"113","author":"Goldstein","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/europace\/eul097","volume":"8","author":"Fuster","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib8","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib10","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts","volume":"163","author":"Fick","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib11","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archfami.4.12.1017","article-title":"Use of warfarin for nonvalvular atrial fibrillation in nursing home patients","volume":"4","author":"Lackner","year":"1995","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib12","doi-asserted-by":"crossref","unstructured":"McCormick D, Gurwitz JH, Goldberg RJ, et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med. 200;161:2458\u20132463.","DOI":"10.1001\/archinte.161.20.2458"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib13","first-page":"15662","article-title":"The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation","volume":"38","author":"Perera","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002512-199914040-00005","article-title":"Safety of treatment with oral anticoagulants in the elderly","volume":"14","author":"Hutten","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00002512-200623010-00002","article-title":"Haemorrhagic complications of vitamin K antagonists in the elderly: risk factors and management","volume":"23","author":"Pautas","year":"2006","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00002512-200016060-00003","article-title":"Use of oral anticoagulants in older patients","volume":"16","author":"Sebastian","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib17","first-page":"203","article-title":"The influence of age, liver size and enantiomer concentrations on warfarin requirements","volume":"40","author":"Wynne","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.clpt.2003.10.001","article-title":"Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin","volume":"75","author":"Kamali","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7326\/0003-4819-116-11-901","article-title":"Aging and the anticoagulant response to warfarin therapy","volume":"116","author":"Gurwitz","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ageing\/20.3.217","article-title":"The association of age with dosage requirement for warfarin","volume":"20","author":"Redwood","year":"1991","journal-title":"Age Ageing"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib21","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1378\/chest.127.6.2049","article-title":"Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population","volume":"127","author":"Garcia","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/ageing\/25.6.429","article-title":"Effect of ageing upon warfarin dose requirements: a longitudinal study","volume":"25","author":"Wynne","year":"1996","journal-title":"Age Ageing"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7326\/0003-4819-121-6-199409150-00009","article-title":"Falls in the nursing home","volume":"121","author":"Rubenstein","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.amjmed.2006.07.045","article-title":"The safety of warfarin therapy in the nursing home setting","volume":"120","author":"Gurwitz","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib25","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"323","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke prevention in atrial fibrillation study","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib27","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib28","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.STR.0000208294.46968.a4","article-title":"Use and effectiveness of warfarin in medicare beneficiaries with atrial fibrillation","volume":"37","author":"Birman-Deych","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib29","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/01.STR.31.6.1217","article-title":"Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission","volume":"31","author":"Cohen","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","article-title":"Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation","volume":"31","author":"Gage","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archinte.1997.00440300080006","article-title":"Atrial fibrillation and stroke prevention with warfarin in the long-term care setting","volume":"157","author":"Gurwitz","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4140\/TCP.n.2011.170","article-title":"Stroke and transient ischemic attack in the long-term care setting: patient characteristics, medication treatment, and length of stay","volume":"26","author":"Meyers","year":"2011","journal-title":"Consult Pharm"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib33","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.STR.0000174293.17959.a1","article-title":"Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10","volume":"36","author":"Kokotailo","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/11318870-000000000-00000","article-title":"Predictors of warfarin use in atrial fibrillation patients in the inpatient setting","volume":"10","author":"Agarwal","year":"2010","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib35","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib36","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","volume":"104","author":"Fuster","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib37","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib38","series-title":"Coumadin (warfarin)","year":"2011"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib41","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors","volume":"43","author":"Birman-Deych","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib42","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1212\/WNL.49.3.660","article-title":"Inaccuracy of the international classification of diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease","volume":"49","author":"Benesch","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib43","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib44","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the united states from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s100720300074","article-title":"Accuracy of ICD-9 codes in identifying ischemic stroke in the General Hospital of Lugo Di Romagna (Italy)","volume":"24","author":"Rinaldi","year":"2003","journal-title":"Neurol Sci"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib46","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0895-4356(01)00480-2","article-title":"Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study","volume":"55","author":"Andrade","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00001648-199601000-00018","article-title":"Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan Hospital automated database","volume":"7","author":"Raiford","year":"1996","journal-title":"Epidemiology"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","article-title":"Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records","volume":"148","author":"Kiyota","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib49","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1161\/01.STR.0000096993.90248.27","article-title":"Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents","volume":"34","author":"Christian","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2215\/CJN.00220605","article-title":"Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey","volume":"1","author":"Liangos","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/00002512-200320110-00003","article-title":"Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist","volume":"20","author":"Rollason","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib52","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1046\/j.1532-5415.2002.50380.x","article-title":"The use of oral anticoagulants (warfarin) in older people","volume":"50","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib53","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0002-9149(99)00813-9","article-title":"Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center","volume":"85","author":"Bradley","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib54","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","article-title":"Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation","volume":"31","author":"Gage","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11319540-000000000-00000","article-title":"Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study","volume":"27","author":"Tulner","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archinte.160.1.41","article-title":"Why do patients with atrial fibrillation not receive warfarin?","volume":"160","author":"Bungard","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib57","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1532-5415.1997.tb05967.x","article-title":"Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners","volume":"45","author":"Monette","year":"1997","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib58","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-154-1-201101040-00289","article-title":"Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation","volume":"154","author":"Freeman","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib60","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archinternmed.2011.314","article-title":"The use of dabigatran in elderly patients","volume":"171","author":"Legrand","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib61","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archinte.163.14.1705","article-title":"Predictors of warfarin use among ohio Medicaid patients with new-onset nonvalvular atrial fibrillation","volume":"163","author":"Johnston","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib62","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-131-12-199912210-00004","article-title":"Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"131","author":"Go","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib63","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/eurheartj\/ehl146","article-title":"Stroke prophylaxis in atrial fibrillation: who gets it and who does not?","volume":"27","author":"Friberg","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib64","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2009.05.046","article-title":"Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years","volume":"54","author":"Poli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib65","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib66","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","article-title":"Systematic overview of warfarin and its drug and food interactions","volume":"165","author":"Holbrook","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2318-8-13","article-title":"Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review","volume":"8","author":"Verhovsek","year":"2008","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib68","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the national registry of atrial fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjopharm.2011.12.001_bib69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am J Med"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154359461100208X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154359461100208X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T13:58:46Z","timestamp":1593525526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154359461100208X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S154359461100208X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2011.12.001","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}